The incumbents have gotten a lot bigger since 2019, so digital health startups will need to change their strategy to get acquired.
In this episode of Second Opinion, Christina Farr is joined by Carine Carmy, CEO of Origin to discuss the overlooked aspects of women's healthcare, a case for a physical clinic, and funding stigmatized fields within the complex healthcare landscape.
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood dive into the intricacies of the behavioral health industry with Alex Katz, CEO of Two Chairs.
Build for the needs of a community, not a single condition
In this episode of Second Opinion, Leslie Schrock, author of Bumpin' and Fertility Rules, joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss women's health.
RCM, transparency tools, HSA/FSAs and more
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood sit down with Owen Tripp, the CEO of Included Health. They discuss the challenges of selling digital health solutions to employers, the importance of clear communication, and how to actually make a difference i
Not all companies (or hormones) are created equal
In this episode of Second Opinion, Meg FitzGerald, a nurse turned private equity investor, offers insights into how VCs and PEs are thinking of investing in healthcare and everything founders should know to raise from both.
In this market, we're undervaluing and underestimating brick and mortar
In this eye-opening episode, Christina Farr and Luba Greenwood dive deep into the challenges big tech faces in healthcare with serial entrepreneur and Cherish CEO Sumit Nagpal.
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Daphne Zohar, CEO of Seaport Therapeutics.
